Physician profile
John J Cogan
NPI 1700886033
$82,159.36
in general payments reported to CMS, 2019-2025
33 companies · $945 in 2025
The $945 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $9,130 · 2021: $4,474 · 2022: $6,755 · 2023: $9,079 · 2024: $4,562 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,439 · Food and Beverage: $6,661 · Consulting Fee: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,439.37 |
| Food and Beverage | $6,661.36 |
| Consulting Fee | $485.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18,583.65 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $13,309.26 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11,601.65 | 2019-2024 | Farxiga, Brilinta |
| Medtronic, INC. | $10,199.21 | 2022-2025 | Micra, Selectsecure, Abre |
| Regeneron Healthcare Solutions, INC. | $6,842.98 | 2019 | |
| Abiomed | $4,919.84 | 2019-2025 | Impella |
| Abbott Laboratories | $4,074.69 | 2019-2024 | Jot Dx, Agilis Hispro, Aveir |
| Corindus INC. | $2,261.28 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,230.29 | 2019-2024 | Jardiance |
| Shockwave Medical, INC | $1,223.94 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $1,057.45 | 2019-2024 | |
| Penumbra, INC. | $1,039.65 | 2024 | Ruby Coil, Penumbra System, Indigo System |
| Boston Scientific Corporation | $956.15 | 2019-2025 | Rotablator Rotational Atherectomy System Console Kit, Avvigo Guidance System, Watchman Flx |
| Amgen INC. | $886.11 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $790.67 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $571.99 | 2023-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $502.48 | 2019-2023 | Lifevest |
| Teleflex LLC | $483.53 | 2022-2025 | Supercross, Guideliner |
| E.R. Squibb & Sons, L.L.C. | $323.50 | 2019-2023 | Eliquis |
| Acist Medical Systems, INC. | $247.50 | 2022-2023 | |
| Esperion Therapeutics, INC. | $198.96 | 2020-2021 | |
| Heartflow, INC. | $165.90 | 2024 | |
| Medtronic Vascular, INC. | $163.15 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.71 | 2021-2025 | |
| Dexcom, INC. | $71.09 | 2023 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $60.48 | 2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $60.27 | 2021-2023 | Verquvo |
| Depuy Synthes Sales INC. | $58.45 | 2025 | Matrixrib |
| Lemaitre Vascular, INC. | $57.08 | 2025 | Restoreflow, Artegraft Vascular Graft |
| Novo Nordisk INC | $40.61 | 2021 | |
| Biotronik INC. | $21.95 | 2020 | |
| Terumo Medical Corporation | $16.07 | 2019 | |
| Cardiovascular Systems INC. | $12.82 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.